Vaccine Scheduler
Italy and Germany: Comparison of recommended vaccinations
| Italy | Germany | |
|---|---|---|
| General recommendation | ||
| Recommendation for specific groups only | ||
| Catch-up (e.g. if previous doses missed) | ||
| Vaccination not funded by the National Health system | ||
| Mandatory vaccination | ||
| Birth | Weeks | Months | Years | ||||||||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 6 | 2 | 3 | 4 | 5 | 6 | 8 | 10 | 11 | 12 | 13 | 14 | 15 | 16 | 18 | 2 | 4 | 5 | 6 | 9 | 12 | 14 | 15-16 | 17 | 18 | |||||
| Coronavirus disease (COVID-19)1, 2 | COVID-196 | ||||||||||||||||||||||||||||
| COVID-197 | |||||||||||||||||||||||||||||
| rotavirus infection | ROTA8 | ||||||||||||||||||||||||||||
| ROTA | ROTA | ROTA9 | |||||||||||||||||||||||||||
| diphtheria | D | D | D | D | d | ||||||||||||||||||||||||
| D | D | D | D | D | d | d | d10 | ||||||||||||||||||||||
| tetanus | TT | TT | TT | TT | TT | ||||||||||||||||||||||||
| TT | TT | TT | TT | TT | TT | TT | TT10 | ||||||||||||||||||||||
| pertussis | acP | acP | acP | acP | acp | ||||||||||||||||||||||||
| acP | acP | acP | acP | acP | acp | acp | acp11 | ||||||||||||||||||||||
| poliomyelitis | IPV | IPV | IPV | IPV | IPV | ||||||||||||||||||||||||
| IPV | IPV12 | IPV | IPV | IPV | IPV | IPV13 | |||||||||||||||||||||||
| Haemophilus influenzae type b infection | Hib | Hib | Hib | ||||||||||||||||||||||||||
| Hib | Hib12 | Hib | Hib | Hib14 | |||||||||||||||||||||||||
| hepatitis B | HepB15 | HepB | HepB | HepB | |||||||||||||||||||||||||
| HepB | HepB12 | HepB | HepB | HepB | |||||||||||||||||||||||||
| pneumococcal disease3 | PCV | PCV | PCV | ||||||||||||||||||||||||||
| PCV13 or PCV 15 | PCV13 or PCV 15 | PCV13 or PCV 15 | PCV13/15+PPSV2316 | PCV2017 | |||||||||||||||||||||||||
| meningococcal disease | MenB18 | MenB18 | MCV4 | MenB18 | MenB18 | MCV419 | |||||||||||||||||||||||
| MenC | MenC | ||||||||||||||||||||||||||||
| measles4 | MEAS | MEAS | |||||||||||||||||||||||||||
| MEAS20 | MEAS | MEAS | MEAS | MEAS21 | |||||||||||||||||||||||||
| mumps | MUMPS | MUMPS | |||||||||||||||||||||||||||
| MUMPS22 | MUMPS | MUMPS | MUMPS | ||||||||||||||||||||||||||
| rubella | RUBE | RUBE | |||||||||||||||||||||||||||
| RUBE22 | RUBE | RUBE | RUBE | ||||||||||||||||||||||||||
| varicella | VAR | VAR | |||||||||||||||||||||||||||
| VAR | VAR | VAR | VAR | ||||||||||||||||||||||||||
| human papillomavirus infection | HPV (F/M)23 | ||||||||||||||||||||||||||||
| HPV (F/M)24 | HPV (F)25 | ||||||||||||||||||||||||||||
| influenza5 | IIV326 | ||||||||||||||||||||||||||||
| hepatitis A | HepA27 | HepA28 | |||||||||||||||||||||||||||
Footnotes:
- http://www.salute.gov.it/portale/documentazione/p6_2_2_1.jsp?lingua=italiano&id=2986
- https://www.rki.de/DE/Content/Infekt/Impfen/ImpfungenAZ/COVID-19/Impfempfehlung-Zusfassung.html
- Premature infants receive an additional vaccine dose at the age of 3 months; in total they receive 4 doses
- For more information on specific population groups where measles vaccination is mandatory please refer to https://www.masernschutz.de/themen/rechtliche-aspekte.html
- TIV may also be replaced by QIV (quadrivalent) or aTIV (adjuvanted TIV) vaccine
- http://www.salute.gov.it/portale/documentazione/p6_2_2_1.jsp?lingua=italiano&id=2986 https://www.salute.gov.it/portale/nuovocoronavirus/dettaglioContenutiNuovoCoronavirus.jsp?lingua=italiano&id=5452&area=nuovoCoronavirus&menu=vuoto
- For a full description of currently applicable COVID-19 recommendations, please refer to https://www.rki.de/DE/Content/Infekt/Impfen/ImpfungenAZ/COVID-19/Impfempfehlung-Zusfassung.html
- Two or three doses depending on the vaccine used (3rd dose only for pentavalent rotavirus vaccines)
- 3rd dose only for pentavalent rotavirus vaccines
- Booster doses every 10 years. catch-up for those unvaccinated
- The next due Td 10-yearly booster dose should be with a Tdacp vaccine. Subsequent booster doses are to be done with Td vaccines. Vaccination offered to pregnant women at the beginning of 3rd trimester. If there is an increased probability of premature birth, vaccination should be brought forward to the 2nd trimester. More information available at: RKI - Vaccinations A - Z - Scientific justification for recommending pertussis vaccination with a Tdap combination vaccine in pregnancy
- optional dosis if monovalent and other combination vaccines are used
- catch-up for those unvaccinated
- number of doses necessary varies according to age
- Babies born to a mother infected with hepatitis B will be offered a first vaccine dose within 12-24 hours after birth and simultaneously with HB immunoglobulin. The following and second vaccine dose is given 4 weeks apart from the first. Starting from the third dose, which is given from 61 days of life onwards, the vaccination calendar schedule including the combined hexavalent vaccine should be used.
- see https://www.rki.de/DE/Content/Infekt/EpidBull/Archiv/2023/Ausgaben/20_23.pdf?__blob=publicationFile for detail on targeted groups
- see recommendation details for at-risk groups where vaccination is recommended https://www.rki.de/DE/Content/Infekt/EpidBull/Archiv/2023/Ausgaben/39_23.pdf?__blob=publicationFile
- Please refer to local recommendations for age of administration. MenB should not to be co-administered with other vaccinations.
- Meningococcal ACWY, one dose for adolescents age 12-18
- Vaccination from 9 months in specific circumstances. In this case, the second dose should be given as early as possible in the second year of life. The 'Measles Protection Act’ was approved in Germany and became effective on March 1st, 2020. It mandates measles vaccination for all children at one year and older that attend a childcare facility.
- one dose of measles for those aged 18 years and older and born after 1970 with no vaccination or uncertain vaccination history or only one vaccination during childhood
- Vaccination from 9 months in specific circumstances. In this case, the second dose should be given as early as possible in the second year of life.
- 9-valent. Gender-neutral (boys and girls) vaccine offered (since 2017). Two-dose or three-dose schedule depending on age. Catch-up available with all doses of the cycle free of charge for women up to 26 years of age and for men up to and including 18 years of age, if they have not been previously vaccinated or have not completed the vaccination cycle.
- Gender-neutral (boys and girls) vaccination offered since 2018. Two-dose schedule at 0 and 6 months (if the interval between doses is <6 months, a third dose is recommended). 2, 4 or 9-valent.
- Girls-only catch-up vaccination offered to girls aged 14-17 or 15-17 years depending on the vaccines used. Three-dose schedule.
- For individuals at increased risk. More information available at: http://www.salute.gov.it/imgs/C_17_pubblicazioni_2571_allegato.pdf
- Recommended in highly endemic areas
- Recommended in highly endemic areas